Synergism between platelet-activating factor (PAF-acether) and prostaglandin E2 in man

Area of Science:

• Immunology
• Dermatology
• Pharmacology

Background:

• Acute inflammation involves edema, a response influenced by blood flow and vasopermeability.
• The "two component hypothesis" posits that both increased blood flow and vasopermeability drive inflammatory edema.
• Understanding these mechanisms is crucial for developing targeted anti-inflammatory therapies.

Purpose of the Study:

• To validate the "two component hypothesis" of acute inflammatory edema in human subjects.
• To investigate the synergistic interaction between platelet-activating factor acetyl (PAF-acether) and prostaglandin E2 (PGE2) in vivo.
• To quantify the combined effect of these mediators on cutaneous wheal volume.

Main Methods:

• Human subjects were administered combinations of PAF-acether and PGE2.
• Cutaneous wheal volume was measured as an indicator of inflammatory response.
• Responses to individual mediators were compared with the response to the combined mixture.

Main Results:

• A synergistic interaction was observed between PAF-acether and PGE2 in humans.
• The combined administration of PAF-acether and PGE2 resulted in a significantly larger wheal volume than predicted by their individual effects.
• This demonstrates that the inflammatory edema response is not merely additive but involves cooperative interactions between mediators.

Conclusions:

• The "two component hypothesis" for acute inflammatory edema is confirmed in humans.
• Platelet-activating factor acetyl and prostaglandin E2 exhibit synergistic effects on inflammatory responses.
• These findings have implications for understanding and potentially treating inflammatory conditions.